Dosage and Protocols of CJC-1295 and Ipamorelin In human trials 5 , single subcutaneous injections of CJC-1295 at ~ 30-60 g/kg produced dose-dependent increases in GH and IGF-1 for 69 days post-dose
Retatrutide was developed as a successor compound to dual incretin agonists (such as tirzepatide), adding glucagon receptor agonism to the GLP-1/GIP profile
Thats, thats one I hadnt thought about and spoken about before, but I love that one
The rate slows somewhat between months 6 and 9 as your body approaches its new equilibrium
Poh CM, Carissimo G, Wang B, Amrun SN, Lee CY, Chee RS, et al
[9] [12] The FDA has approved various formulations for different indications, with growing clinical use across multiple patient populations